Using aldehyde dehydrogenase 1 (ALDH1) as a marker for CSC in HNSCC, Chen et al. showed that HNSCC ALDH1+ cells were tumorigenic and displayed resistance towards radiotherapy [63]. This evidence concerns the gene ALDH1A1 and head and neck squamous cell carcinoma.